Celldex Therapeutics, Inc (CLDX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CLDX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 245 institutions reported holding CLDX, with 85.0 million shares worth $3.2 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Wellington Management | 9,543,671 | $355M | INCREASED |
| BlackRock | 7,002,530 | $261M | INCREASED |
| Kynam Capital Management | 5,322,908 | $198M | DECREASED |
| Vanguard | 4,984,374 | $185M | INCREASED |
| T. Rowe Price | 4,685,223 | $174M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Celldex Therapeutics, Inc on SentiSense.